Baystate Wealth Management’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$1.18K Hold
2
﹤0.01% 1137
2023
Q3
$1.04K Hold
2
﹤0.01% 885
2023
Q2
$1.09K Hold
2
﹤0.01% 923
2023
Q1
$1.08K Hold
2
﹤0.01% 924
2022
Q4
$1K Hold
2
﹤0.01% 843
2022
Q3
$1K Hold
2
﹤0.01% 797
2022
Q2
$1K Hold
2
﹤0.01% 822
2022
Q1
$1K Hold
2
﹤0.01% 809
2021
Q4
$1K Hold
2
﹤0.01% 809
2021
Q3
$1K Hold
2
﹤0.01% 737
2021
Q2
$1K Hold
2
﹤0.01% 708
2021
Q1
$1K Buy
+2
New +$980 ﹤0.01% 640
2019
Q2
Sell
-47
Closed -$15K 648
2019
Q1
$15K Hold
47
﹤0.01% 333
2018
Q4
$13K Buy
+47
New +$14.2K ﹤0.01% 346

Other funds holding CHE

Baystate Wealth Management's CHE Position: Q4 2023 in Review

Baystate Wealth Management held its Chemed (CHE) position steady in Q4 2023 at 2 shares worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #1137.

Baystate Wealth Management first reported a position in CHE in Q4 2018 and has held it in 14 quarters since. The position peaked at $15K in Q1 2019. 501 funds tracked by Wall St. Rank hold CHE as of Q4 2023.

  • Baystate Wealth Management held 2 shares of Chemed worth $1.18K as of Q4 2023.
  • Baystate Wealth Management left its Chemed share count unchanged in Q4 2023.
  • Chemed made up ﹤0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #1137 holding.
  • Baystate Wealth Management first reported a position in Chemed in Q4 2018 and has held it in 14 quarters since.
  • Baystate Wealth Management's Chemed position peaked at $15K in Q1 2019.
  • 501 funds tracked by Wall St. Rank held Chemed as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.